Dihydrosesamin是一种天然产物，属于柏科扁柏属，其产品编号为 TN3865，CAS号为 83708-70-7。Dihydrosesamin可用作对照参考。

N-Nornuciferine 是存在于莲叶中的阿朴啡类生物碱，能够强效抑制 CYP2D6，其 IC50 为 3.76 μM、Ki 为 2.34 μM。药动学研究表明其可迅速吸收入血，在给药 0.9 h 与 1.65 h 分别达到 Cmax 1.71 μg/mL 与 0.57 μg/mL。静脉给药（10 mg/kg）后分布容积为 9.48–15.17 L/kg，消除半衰期为 2.09–3.84 h；口服生物利用度为 58.13–79.91%。在 20 mg/kg 静脉给药下，其可快速穿越血脑屏障，于 0.89–1.22 h 达到游离 Cmax 值 0.32 μg/mL 与 0.16 μg/mL。

Kushenol K is a potent and Selective Inhibitor of cGMP Phosphodiesterase 5, it also has inhibitory effects on diacylglycerol acyltransferase (DGAT). Kushenol K shows weak antiviral activity against Herpes simplex virus types I and II.

N-Demethyldiltiazem HCl 是一种非二氢吡啶类钙通道阻断剂。

(S)-Orteronel ((S)-Orteronel) 是人17，20-裂解酶 (17,20-lyase, CYP17) 选择性抑制剂(IC50:38 nM)，CYP17对(S)-Orteronel 选择性比对 11-hydroxylase 及 CYP3A4 高 1000 多倍。

fluorometric substrate of cytochrome P450

Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)13(14)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 13,14-double bond of DHA. It has been detected in rat brain and spinal cord and is a preferred substrate for soluble epoxide hydrolase with a Km value of 3.2 μM. (±)13(14)-EpDPA demonstrates antihyperalgesic activity in inflammatory and neuropathic pain models. (±)13(14)-EpDPA and other epoxy metabolites of DHA are also reported to potently inhibit angiogenesis and tumor growth in in vitro assays.

6-Hydroxywarfarin 是(+)-华法林的代谢物，也一种较弱的维生素 K 拮抗剂。

Proadifen is a non-selective cytochrome P450 enzymes inhibitor, preventing some types of drug metabolism.